In a mouse model of pancreatic cancer, inhibition of CSF1R signaling suppresses TAMs accumulation and their immune suppressive functions, and thereby synergize with checkpoint-blockade immunotherapy (13). Here, CSF1R is linked to familial pancreatic carcinoma.